Litifilimab (BIIB059)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Litifilimab (BIIB059), covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus [Phase 3]